Covid-19-Associated Myopathy Caused by Type I Interferonopathy

N Engl J Med. 2020 Dec 10;383(24):2389-2390. doi: 10.1056/NEJMc2031085. Epub 2020 Nov 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Adult
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • COVID-19 / complications*
  • Humans
  • Interferon Type I / metabolism*
  • Male
  • Methylprednisolone / therapeutic use
  • Muscle, Skeletal / pathology
  • Muscular Diseases / virology*
  • Myxovirus Resistance Proteins / metabolism
  • Prednisone / therapeutic use

Substances

  • Interferon Type I
  • Myxovirus Resistance Proteins
  • remdesivir
  • Adenosine Monophosphate
  • Alanine
  • Prednisone
  • Methylprednisolone